Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Genocea Biosciences, Inc. (GNCA)  
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,640,000
Market Cap: 30.69(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5943 - $0.5943
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its proprietary ATLAS™ platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. GEN-011 is an investigational solid tumor cell therapy candidate comprised of CD4+ and CD8+ neoantigen-targeted peripheral T cells. GEN-011 is comprised of T cells extracted from the patient's peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 93,582,981
Total Sell Value $0 $0 $0 $6,768,648
Total People Sold 0 0 0 15
Total Sell Transactions 0 0 0 27
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 182
  Page 6 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Clark William D President and CEO   •       •      –    2016-11-07 4 B $3.49 $9,772 D/D 2,800 52,205 2.81     -
   Poole Jonathan Chief Financial Officer   •       –      –    2016-05-09 4 B $3.88 $15,520 D/D 4,000 8,213 2.74     -
   Clark William D President and CEO   •       •      –    2015-12-16 4 B $6.45 $24,510 D/D 3,800 43,607 2.81     -
   Flechtner Jessica Baker VP of Research   •       –      –    2015-12-14 4 OE $2.02 $17,990 D/D 8,906 10,787     -
   Hetherington Seth V Chief Medical Officer   •       –      –    2015-12-11 4 OE $2.02 $10,100 D/D 5,000 21,000     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-09-01 4 AS $11.35 $25,299 D/D (2,229) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-09-01 4 OE $2.02 $4,503 D/D 2,229 4,110     -
   Hetherington Seth V Chief Medical Officer   •       –      –    2015-08-07 4 OE $2.02 $10,100 D/D 5,000 16,000     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-08-03 4 AS $13.05 $29,088 D/D (2,229) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-08-03 4 OE $2.02 $4,503 D/D 2,229 4,110     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-07-01 4 AS $13.92 $31,028 D/D (2,229) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-07-01 4 OE $2.02 $4,503 D/D 2,229 4,110     -
   Polaris Venture Partners Special Founders Fund V, 10% Owner   –       –       •   2015-06-19 4 S $13.00 $13,000 I/I (1,000) 1,968,606     -
   Polaris Venture Partners Special Founders Fund V, 10% Owner   –       –       •   2015-06-18 4 S $13.04 $378,212 I/I (29,004) 1,969,606     -
   Polaris Venture Partners Special Founders Fund V, 10% Owner   –       –       •   2015-06-17 4 S $13.01 $138,140 I/I (10,618) 1,998,610     -
   Polaris Venture Partners Special Founders Fund V, 10% Owner   –       –       •   2015-06-16 4 S $13.24 $609,040 I/I (46,000) 2,009,228     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-06-01 4 AS $10.52 $23,449 D/D (2,229) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-06-01 4 OE $2.02 $4,503 D/D 2,229 4,110     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-05-01 4 AS $10.21 $22,758 D/D (2,229) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-05-01 4 OE $2.02 $4,503 D/D 2,229 4,110     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-04-01 4 AS $11.77 $26,871 D/D (2,283) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-04-01 4 OE $2.86 $6,529 D/D 2,283 4,164     -
   Hoffman Stephen J Director   –       •      –    2015-03-17 4 B $8.25 $5,775,000 I/I 700,000 1,992,415 2.1     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-03-02 4 AS $8.50 $31,909 D/D (3,754) 1,881     -
   Flechtner Jessica Baker Sr. VP of Research   •       –      –    2015-03-02 4 OE $2.38 $10,031 D/D 3,754 4,165     -
  182 Records found
  1  2  3  4  5  6  7  8   
  Page 6 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us